BHCM
Brevan Howard Capital Management Portfolio holdings
AUM
$9.09B
This Quarter Return
-0.16%
1 Year Return
+13.74%
3 Year Return
+18.18%
5 Year Return
–
10 Year Return
–
AUM
$337M
AUM Growth
+$337M
(-38%)
Cap. Flow
-$187M
Cap. Flow
% of AUM
-55.38%
Top 10 Holdings %
Top 10 Hldgs %
44.1%
Holding
420
New
234
Increased
33
Reduced
22
Closed
60
Top Buys
| 1 |
Financial Select Sector SPDR Fund
XLF
|
$12.4M |
| 2 |
SGEN
Seagen Inc. Common Stock
SGEN
|
$5.82M |
| 3 |
Walt Disney
DIS
|
$5.62M |
| 4 |
Invesco Senior Loan ETF
BKLN
|
$3.67M |
| 5 |
WW
WW International
WW
|
$3.21M |
Top Sells
| 1 |
iShares 20+ Year Treasury Bond ETF
TLT
|
$86.8M |
| 2 |
iShares JPMorgan USD Emerging Markets Bond ETF
EMB
|
$51.9M |
| 3 |
iShares MSCI Brazil ETF
EWZ
|
$23M |
| 4 |
Global X Uranium ETF
URA
|
$20.5M |
| 5 |
iShares MSCI Emerging Markets ETF
EEM
|
$20.1M |
Sector Composition
| 1 | Healthcare | 13.76% |
| 2 | Technology | 11.12% |
| 3 | Financials | 9.6% |
| 4 | Consumer Discretionary | 7.9% |
| 5 | Industrials | 5.48% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
301
Altice USA
ATUS
$1.1B
| $47.6K | ﹤0.01% |
+14,565
| New | +$47.6K |
|
302
Rayonier Advanced Materials
RYAM
$396M
| $47.2K | ﹤0.01% |
+13,338
| New | +$47.2K |
|
303
Emergent Biosolutions
EBS
$434M
| $46.9K | ﹤0.01% |
+13,781
| New | +$46.9K |
|
304
fuboTV
FUBO
$1.26B
| $44.6K | ﹤0.01% |
+16,687
| New | +$44.6K |
|
305
Coherus Oncology, Inc. Common Stock
CHRS
$143M
| $42.8K | ﹤0.01% |
+11,452
| New | +$42.8K |
|
306
Gannett
GCI
$592M
| $39.1K | ﹤0.01% |
+15,975
| New | +$39.1K |
|
307
Vimeo
VMEO
$676M
| $37K | ﹤0.01% |
+10,457
| New | +$37K |
|
308
Fate Therapeutics
FATE
$115M
| $36.8K | ﹤0.01% |
+17,337
| New | +$36.8K |
|
309
Microvast
MVST
$851M
| $35K | ﹤0.01% |
+18,508
| New | +$35K |
|
310
Opko Health
OPK
$1.1B
| $32.2K | ﹤0.01% |
+20,153
| New | +$32.2K |
|
311
Clover Health Investments
CLOV
$1.35B
| $31K | ﹤0.01% |
+28,693
| New | +$31K |
|
312
Karyopharm Therapeutics
KPTI
$59.7M
| $30.6K | ﹤0.01% |
+22,824
| New | +$30.6K |
|
313
8x8 Inc
EGHT
$267M
| $28.9K | ﹤0.01% |
+11,458
| New | +$28.9K |
|
|
TELL
314
DELISTED
Tellurian Inc.
TELL
| $28.3K | ﹤0.01% |
+24,407
| New | +$28.3K |
|
315
Ring Energy
REI
$205M
| $20.7K | ﹤0.01% |
+10,596
| New | +$20.7K |
|
316
Gevo
GEVO
$404M
| $20.6K | ﹤0.01% |
+17,273
| New | +$20.6K |
|
|
AGEN
317
Agenus
AGEN
$138M
| $18.2K | ﹤0.01% |
+16,130
| New | +$18.2K |
|
|
CTEV
318
Claritev Corporation
CTEV
$1.14B
| $17.1K | ﹤0.01% |
+10,173
| New | +$17.1K |
|
319
Mersana Therapeutics
MRSN
$35.6M
| $13K | ﹤0.01% |
+10,238
| New | +$13K |
|
|
QVCGA
320
QVC Group, Inc. Series A Common Stock
QVCGA
$71.4M
| $10K | ﹤0.01% |
16,510
-30,000
| -65% | -$18.2K |
|
321
AerCap
AER
$22.1B
| – | – |
0
| – | – |
|
322
Applied Materials
AMAT
$124B
| – | – |
-15,000
| Closed | -$2.17M |
|
323
AMC Entertainment Holdings
AMC
$1.4B
| – | – |
0
| – | – |
|
324
AMC Networks
AMCX
$313M
| – | – |
0
| – | – |
|
325
Advanced Micro Devices
AMD
$261B
| – | – |
-10,000
| Closed | -$1.14M |
|